[31] Use and selectivity of herbimycin A as inhibitor of protein-tyrosine kinases
- 1 January 1991
- book chapter
- Published by Elsevier BV in Methods in enzymology
- Vol. 201, 370-379
- https://doi.org/10.1016/0076-6879(91)01033-x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Effects of herbimycin A and various SH-reagents on p60v-src kinase activity invitroBiochemical and Biophysical Research Communications, 1990
- Irreversible inhibition of v-src tyrosine kinase activity by herbimycin a and its abrogation by sulfhydryl compoundsBiochemical and Biophysical Research Communications, 1989
- Induction of in vitro differentiation of mouse embryonal carcinoma (F9) and erythroleukemia (MEL) cells by herbimycin A, an inhibitor of protein phosphorylation.The Journal of cell biology, 1989
- A new activity of herbimycin A: Inhibition of angiogenesis.The Journal of Antibiotics, 1989
- Powerful antiangiogenic activity of herbimycin A (named angiostatic antibiotic).The Journal of Antibiotics, 1989
- A host-dependent temperature-sensitive mutant of rous sarcoma virus: Evidence for host factors affecting transformationVirology, 1988
- Inhibition of transforming activity of tyrosine kinase oncogenes by herbimycin AVirology, 1988
- Induction of angiogenesis in vitro by vanadate, an inhibitor of phosphotyrosine phosphatasesJournal of Cellular Physiology, 1988
- Herbimycin, a new antibiotic produced by a strain of Streptomyces.The Journal of Antibiotics, 1979
- Properties of mammalian cells transformed by temperature-sensitive mutants of avian sarcoma virusCell, 1977